<?xml version="1.0"?>
<oembed><version>1.0</version><provider_name>KFF Health News</provider_name><provider_url>https://kffhealthnews.org</provider_url><author_name>brilabuskes</author_name><author_url>https://kffhealthnews.org/news/author/brilabuskes/</author_url><title>A Price Tag On Hope: As Pharma Companies Eye Right To Try, Profit Motives Overtake Any Expected Altruism - KFF Health News</title><type>rich</type><width>600</width><height>338</height><html>&lt;blockquote class="wp-embedded-content" data-secret="ciMxsyefjR"&gt;&lt;a href="https://kffhealthnews.org/morning-breakout/a-price-tag-on-hope-as-pharma-companies-eye-right-to-try-profit-motives-overtake-any-expected-altruism/"&gt;A Price Tag On Hope: As Pharma Companies Eye Right To Try, Profit Motives Overtake Any Expected Altruism&lt;/a&gt;&lt;/blockquote&gt;&lt;iframe sandbox="allow-scripts" security="restricted" src="https://kffhealthnews.org/morning-breakout/a-price-tag-on-hope-as-pharma-companies-eye-right-to-try-profit-motives-overtake-any-expected-altruism/embed/#?secret=ciMxsyefjR" width="600" height="338" title="&#x201C;A Price Tag On Hope: As Pharma Companies Eye Right To Try, Profit Motives Overtake Any Expected Altruism&#x201D; &#x2014; KFF Health News" data-secret="ciMxsyefjR" frameborder="0" marginwidth="0" marginheight="0" scrolling="no" class="wp-embedded-content"&gt;&lt;/iframe&gt;&lt;script type="text/javascript"&gt;
/* &lt;![CDATA[ */
/*! This file is auto-generated */
!function(d,l){"use strict";l.querySelector&amp;&amp;d.addEventListener&amp;&amp;"undefined"!=typeof URL&amp;&amp;(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&amp;&amp;!/[^a-zA-Z0-9]/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret="'+t.secret+'"]'),o=l.querySelectorAll('blockquote[data-secret="'+t.secret+'"]'),c=new RegExp("^https?:$","i"),i=0;i&lt;o.length;i++)o[i].style.display="none";for(i=0;i&lt;a.length;i++)s=a[i],e.source===s.contentWindow&amp;&amp;(s.removeAttribute("style"),"height"===t.message?(1e3&lt;(r=parseInt(t.value,10))?r=1e3:~~r&lt;200&amp;&amp;(r=200),s.height=r):"link"===t.message&amp;&amp;(r=new URL(s.getAttribute("src")),n=new URL(t.value),c.test(n.protocol))&amp;&amp;n.host===r.host&amp;&amp;l.activeElement===s&amp;&amp;(d.top.location.href=t.value))}},d.addEventListener("message",d.wp.receiveEmbedMessage,!1),l.addEventListener("DOMContentLoaded",function(){for(var e,t,s=l.querySelectorAll("iframe.wp-embedded-content"),r=0;r&lt;s.length;r++)(t=(e=s[r]).getAttribute("data-secret"))||(t=Math.random().toString(36).substring(2,12),e.src+="#?secret="+t,e.setAttribute("data-secret",t)),e.contentWindow.postMessage({message:"ready",secret:t},"*")},!1)))}(window,document);
/* ]]&gt; */
&lt;/script&gt;
</html><description>&#x201C;Companies cannot be NGOs,&#x201D; Brainstorm CEO Chaim Lebovits said. &#x201C;We have to have an incentive.&#x201D; Health insurers don&#x2019;t typically pay for treatments that haven&#x2019;t been approved by regulators or proven to work in clinical trials. That means patients would have to pay for the therapies, which could reach into the hundreds of thousands of dollars, out of their own pockets.</description></oembed>
